BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663-671. [PMID: 10561090 DOI: 10.1097/00000658-199911000-00008] [Cited by in Crossref: 254] [Cited by in F6Publishing: 231] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Maeda A, Goto S, Iwasaki R, Yamada K, Murakami M, Sakai H, Mori T. Outcome of Localized Bile Duct Carcinoma in Six Dogs Treated with Liver Lobectomy. J Am Anim Hosp Assoc 2022;58:189-93. [PMID: 35793487 DOI: 10.5326/JAAHA-MS-7199] [Reference Citation Analysis]
2 Khan J, Ullah A, Matolo N, Waheed A, Nama N, Khan T, Tareen B, Khan Z, Singh SG, Cason FD. Klatskin Tumor in the Light of ICD-O-3: A Population-Based Clinical Outcome Study Involving 1,144 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (2001-2012). Cureus 2021;13:e18941. [PMID: 34815893 DOI: 10.7759/cureus.18941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Shamsuddin F, Mallik MK, Hussein S, Alali AA, Kapila K. Cholangiocarcinoma: A diagnostic dilemma on cytology. Cytopathology 2021. [PMID: 34729840 DOI: 10.1111/cyt.13073] [Reference Citation Analysis]
4 Abdelrahim M, Esmail A, Abudayyeh A, Murakami N, Saharia A, McMillan R, Victor D, Kodali S, Shetty A, Nolte Fong JV, Moore LW, Heyne K, Gaber AO, Ghobrial RM. Transplant Oncology: An Evolving Field in Cancer Care. Cancers (Basel) 2021;13:4911. [PMID: 34638395 DOI: 10.3390/cancers13194911] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
5 Istanbouli A, Patel S, Almerey T, Li Z, Stauffer JA. Surgical Treatment for Intrahepatic, Peri-Hilar, and Distal Cholangiocarcinoma: 20-Single Institutional Year Experience. Am Surg 2021;:31348211034751. [PMID: 34314644 DOI: 10.1177/00031348211034751] [Reference Citation Analysis]
6 Liang L, Li C, Wang MD, Xing H, Diao YK, Jia HD, Lau WY, Pawlik TM, Zhang CW, Shen F, Huang DS, Yang T. The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis. Int J Clin Oncol 2021;26:1575-86. [PMID: 34160742 DOI: 10.1007/s10147-021-01967-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Tang W, Qiu JG, Deng X, Liu SS, Cheng L, Liu JR, Du CY. Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness. PLoS One 2021;16:e0248534. [PMID: 33705481 DOI: 10.1371/journal.pone.0248534] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Liang L, Li C, Jia HD, Diao YK, Xing H, Pawlik TM, Lau WY, Shen F, Huang DS, Zhang CW, Yang T. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies. Ther Adv Gastrointest Endosc 2021;14:2631774521993065. [PMID: 33629062 DOI: 10.1177/2631774521993065] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Kamada Y, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Yazawa T, Tani M, Sato A, Tani R, Aoyama R, Sasaki Y, Zaima M. Surgical treatment of gallbladder cancer: An eight-year experience in a single center. World J Hepatol 2020; 12(9): 641-660 [PMID: 33033570 DOI: 10.4254/wjh.v12.i9.641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Komatsubara T, Sakuma Y, Sata N, Fukushima N. Histological evaluation of tumor differentiation score and prognosis of extrahepatic bile duct cancer: A proposal for a new histological grading system. Pathol Int 2020;70:857-64. [PMID: 32909295 DOI: 10.1111/pin.13014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Li J, Zhou MH, Ma WJ, Li FY, Deng YL. Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring? World J Gastroenterol 2020; 26(24): 3318-3325 [PMID: 32655260 DOI: 10.3748/wjg.v26.i24.3318] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
12 Singhi AD, Nikiforova MN, Chennat J, Papachristou GI, Khalid A, Rabinovitz M, Das R, Sarkaria S, Ayasso MS, Wald AI, Monaco SE, Nalesnik M, Ohori NP, Geller D, Tsung A, Zureikat AH, Zeh H, Marsh JW, Hogg M, Lee K, Bartlett DL, Pingpank JF, Humar A, Bahary N, Dasyam AK, Brand R, Fasanella KE, McGrath K, Slivka A. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Gut 2020;69:52-61. [PMID: 30971436 DOI: 10.1136/gutjnl-2018-317817] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 28.0] [Reference Citation Analysis]
13 Moris D, Kostakis ID, Machairas N, Prodromidou A, Tsilimigras DI, Ravindra KV, Sudan DL, Knechtle SJ, Barbas AS. Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis. PLoS One. 2019;14:e0220527. [PMID: 31365594 DOI: 10.1371/journal.pone.0220527] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
14 Galperin EI, Akhaladze GG, Vetshev PS, Dyuzheva TG. Differentiated approach to the minimally invasive management of malignant obstructive jaundice. Ann hir gepatol 2019;24:10-24. [DOI: 10.16931/1995-5464.2019210-24] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
15 Koo T, Park HJ, Kim K. Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives. World J Clin Cases 2019; 7(11): 1242-1252 [PMID: 31236388 DOI: 10.12998/wjcc.v7.i11.1242] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Malik AK, Robinson SM, French JJ, Sen G, Wilson CH, Hammond JS, White SA, Manas DM. Surgery for Hilar cholangiocarcinoma: the Newcastle upon Tyne Liver Unit experience. Eur Surg 2019;51:197-205. [DOI: 10.1007/s10353-019-0599-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Kikuchi Y, Matuyama R, Hiroshima Y, Murakami T, Bouvet M, Morioka D, Hoffman RM, Endo I. Surgical and histological boundary of the hepatic hilar plate system: basic study relevant to surgery for hilar cholangiocarcinoma regarding the "true" proximal ductal margin. J Hepatobiliary Pancreat Sci 2019;26:159-68. [PMID: 30825363 DOI: 10.1002/jhbp.617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Komatsubara T, Oshiro H, Sakuma Y, Sata N, Niki T, Fukushima N. Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer. Pathol Int 2019;69:86-93. [PMID: 30729623 DOI: 10.1111/pin.12769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Lee Y, Choi D, Han S, Han IW, Heo JS, Choi SH. Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2018;22:350-8. [PMID: 30588526 DOI: 10.14701/ahbps.2018.22.4.350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
20 Donati M, Stang A, Stavrou GA, Basile F, Oldhafer KJ. Extending resectability of hilar cholangiocarcinomas: how can it be assessed and improved? Future Oncol 2019;15:193-205. [PMID: 30378439 DOI: 10.2217/fon-2018-0413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kapoor BS, Mauri G, Lorenz JM. Management of Biliary Strictures: State-of-the-Art Review.Radiology. 2018;289:590-603. [PMID: 30351249 DOI: 10.1148/radiol.2018172424] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
22 Tang Z, Yang Y, Zhao Z, Wei K, Meng W, Li X. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e11999. [PMID: 30142840 DOI: 10.1097/MD.0000000000011999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
23 Yu Z, Zhu J, Jiang H, He C, Xiao Z, Wang J, Xu J. Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma. Indian J Surg 2018;80:309-17. [PMID: 32288384 DOI: 10.1007/s12262-016-1581-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Wakai T, Sakata J, Katada T, Hirose Y, Soma D, Prasoon P, Miura K, Kobayashi T. Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma. Ann Gastroenterol Surg 2018;2:359-66. [PMID: 30238077 DOI: 10.1002/ags3.12196] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
25 Quinn LM, Dunne DFJ, Jones RP, Poston GJ, Malik HZ, Fenwick SW. Optimal perioperative care in peri-hilar cholangiocarcinoma resection. Eur Surg 2018;50:93-9. [PMID: 29875797 DOI: 10.1007/s10353-018-0529-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Park HJ, Kim SY, Kim HJ, Lee SS, Hong GS, Byun JH, Hong SM, Lee MG. Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features. AJR Am J Roentgenol. 2018;211:67-75. [PMID: 29629808 DOI: 10.2214/ajr.17.19261] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
27 Ecker BL, Vining CC, Roses RE, Maggino L, Lee MK, Drebin JA, Fraker DL, Vollmer CM, Datta J. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2017;24:3926-3933. [PMID: 28952140 DOI: 10.1245/s10434-017-6095-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
28 Rosen CB, Heimbach JK, Gores GJ. Current status of liver transplantation for hilar cholangiocarcinoma. Curr Opin Organ Transplant 2007;12:215-9. [PMID: 27711007 DOI: 10.1097/MOT.0b013e32814e6b7d] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Lorenz JM. Management of Malignant Biliary Obstruction. Semin Intervent Radiol. 2016;33:259-267. [PMID: 27904244 DOI: 10.1055/s-0036-1592330] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
30 Elias Y, Mariano AT Jr, Lu Y. Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT. World J Nucl Med 2016;15:161-6. [PMID: 27651736 DOI: 10.4103/1450-1147.167605] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349-1369. [PMID: 26799932 DOI: 10.1002/cncr.29692] [Cited by in Crossref: 97] [Cited by in F6Publishing: 128] [Article Influence: 16.2] [Reference Citation Analysis]
32 Slivka A, Gan I, Jamidar P, Costamagna G, Cesaro P, Giovannini M, Caillol F, Kahaleh M. Validation of the diagnostic accuracy of probe-based confocal laser endomicroscopy for the characterization of indeterminate biliary strictures: results of a prospective multicenter international study. Gastrointest Endosc. 2015;81:282-290. [PMID: 25616752 DOI: 10.1016/j.gie.2014.10.009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 10.0] [Reference Citation Analysis]
33 Gulamhusein AF, Sanchez W. Liver transplantation in the management of perihilar cholangiocarcinoma. Hepat Oncol 2015;2:409-21. [PMID: 30191020 DOI: 10.2217/hep.15.30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
34 Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Isayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015;22:249-273. [PMID: 25787274 DOI: 10.1002/jhbp.233] [Cited by in Crossref: 138] [Cited by in F6Publishing: 114] [Article Influence: 19.7] [Reference Citation Analysis]
35 Howell M, Valle JW. The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma. Best Pract Res Clin Gastroenterol 2015;29:333-43. [PMID: 25966432 DOI: 10.1016/j.bpg.2015.03.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
36 Kobayashi N, Watanabe S, Hosono K, Kubota K, Nakajima A, Kaneko T, Sugimori K, Tokuhisa M, Goto A, Mori R. Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol. 2015;15:8. [PMID: 25649526 DOI: 10.1186/s12876-015-0233-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
37 Kimura N, Toyoki Y, Ishido K, Kudo D, Yakoshi Y, Tsutsumi S, Miura T, Wakiya T, Hakamada K. Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma. J Gastrointest Surg 2015;19:866-79. [PMID: 25605416 DOI: 10.1007/s11605-014-2741-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
38 Oguro S, Esaki M, Kishi Y, Nara S, Shimada K, Ojima H, Kosuge T. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma. Ann Surg Oncol 2015;22:1915-24. [PMID: 25404474 DOI: 10.1245/s10434-014-4232-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
39 Kambakamba P, Deoliveira ML. Perihilar cholangiocarcinoma: paradigms of surgical management. The American Journal of Surgery 2014;208:563-70. [DOI: 10.1016/j.amjsurg.2014.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
40 Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol 2014; 5(3): 344-354 [PMID: 25133034 DOI: 10.4291/wjgp.v5.i3.344] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
41 Koo TR, Eom KY, Kim IA, Cho JY, Yoon YS, Hwang DW, Han HS, Kim JS. Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy. Radiat Oncol J. 2014;32:63-69. [PMID: 25061574 DOI: 10.3857/roj.2014.32.2.63] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
42 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 54] [Reference Citation Analysis]
43 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
44 Noji T, Tsuchikawa T, Okamura K, Shichinohe T, Tanaka E, Hirano S. Surgical Outcome of Hilar Plate Resection: Extended Hilar Bile Duct Resection Without Hepatectomy. J Gastrointest Surg 2014;18:1131-7. [DOI: 10.1007/s11605-014-2490-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
45 Lee SJ, Kwon W, Kang MJ, Jang JY, Chang YR, Jung W, Kim SW. Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma. Korean J Hepatobiliary Pancreat Surg 2014;18:1-8. [PMID: 26155239 DOI: 10.14701/kjhbps.2014.18.1.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Ebata T, Kosuge T, Hirano S, Unno M, Yamamoto M, Miyazaki M, Kokudo N, Miyagawa S, Takada T, Nagino M. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg. 2014;101:79-88. [PMID: 24375300 DOI: 10.1002/bjs.9379] [Cited by in Crossref: 84] [Cited by in F6Publishing: 127] [Article Influence: 10.5] [Reference Citation Analysis]
47 Singal A, Welling TH, Marrero JA. Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Review of Anticancer Therapy 2014;9:491-502. [DOI: 10.1586/era.09.5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
48 Robles R, Sánchez-Bueno F, Ramírez P, Brusadin R, Parrilla P. Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol 2013; 19(48): 9209-9215 [PMID: 24409049 DOI: 10.3748/wjg.v19.i48.9209] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
49 Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51. [PMID: 30190940 DOI: 10.2217/hep.13.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
50 Furusawa N, Kobayashi A, Yokoyama T, Shimizu A, Motoyama H, Miyagawa S. Surgical Treatment of 144 Cases of Hilar Cholangiocarcinoma Without Liver-Related Mortality. World J Surg 2014;38:1164-76. [DOI: 10.1007/s00268-013-2394-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
51 Zhimin G, Noor H, Jian-Bo Z, Lin W, Jha RK. Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review. Med Sci Monit. 2013;19:648-656. [PMID: 23921971 DOI: 10.12659/msm.889379] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
52 Serrablo A, Tejedor L. Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol 2013; 5(7): 147-158 [PMID: 23919109 DOI: 10.4251/wjgo.v5.i7.147] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
53 Ramos E. Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol 2013; 5(7): 139-146 [PMID: 23919108 DOI: 10.4251/wjgo.v5.i7.139] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
54 Kang MJ, Jang J, Kwon W, Park JW, Chang YR, Kim S. Does Preoperative Portal Vein Embolization Have Any Impact on the Outcome of Right-Side Hepatectomy for Klatskin Tumor? J Gastrointest Surg 2013;17:1592-9. [DOI: 10.1007/s11605-013-2247-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
55 Ray CE Jr, Lorenz JM, Burke CT, Darcy MD, Fidelman N, Greene FL, Hohenwalter EJ, Kinney TB, Kolbeck KJ, Kostelic JK, Kouri BE, Nair AV, Owens CA, Rochon PJ, Rockey DC, Vatakencherry G. ACR Appropriateness Criteria radiologic management of benign and malignant biliary obstruction. J Am Coll Radiol 2013;10:567-74. [PMID: 23763879 DOI: 10.1016/j.jacr.2013.03.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
56 Sugiyama H, Tsuyuguchi T, Sakai Y, Ohtsuka M, Miyazaki M, Yokosuka O. Potential role of peroral cholangioscopy for preoperative diagnosis of cholangiocarcinoma. Surg Laparosc Endosc Percutan Tech 2012;22:532-6. [PMID: 23238382 DOI: 10.1097/SLE.0b013e3182686178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
57 Esaki M, Shimada K, Nara S, Kishi Y, Sakamoto Y, Kosuge T, Sano T. Left hepatic trisectionectomy for advanced perihilar cholangiocarcinoma. Br J Surg. 2013;100:801-807. [PMID: 23460314 DOI: 10.1002/bjs.9099] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
58 Kobayashi S, Nagano H, Marubashi S, Kawamoto K, Wada H, Eguchi H, Tanemura M, Umeshita K, Doki Y, Mori M. Clinicopathological features of long-term survivors for advanced biliary tract cancer and impact of the number of lymph nodes involved. Int J Surg 2013;11:145-51. [PMID: 23298575 DOI: 10.1016/j.ijsu.2012.12.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
59 Khashab MA, Fockens P, Al-haddad MA. Utility of EUS in patients with indeterminate biliary strictures and suspected extrahepatic cholangiocarcinoma (with videos). Gastrointestinal Endoscopy 2012;76:1024-33. [DOI: 10.1016/j.gie.2012.04.451] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
60 Yamamoto J, Yamamoto H, Nishikawa M, Moriya T, Hatsuse K, Tsujimoto H, Ueno H, Hashiguchi Y, Hase K, Shinmoto H, Kaji T. Right-sided retrocaval approach using guidance via the lesser sac for Spieghel lobe resection. Surgery 2013;153:282-6. [PMID: 23022074 DOI: 10.1016/j.surg.2012.02.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Cheng QB, Yi B, Wang JH, Jiang XQ, Luo XJ, Liu C, Ran RZ, Yan PN, Zhang BH. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol. 2012;38:1197-1203. [PMID: 22992326 DOI: 10.1016/j.ejso.2012.08.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
62 Gumbs AA, Jarufe N, Gayet B. Minimally invasive approaches to extrapancreatic cholangiocarcinoma. Surg Endosc 2013;27:406-14. [PMID: 22926892 DOI: 10.1007/s00464-012-2489-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
63 Singh MK, Facciuto ME. Current management of cholangiocarcinoma. Mt Sinai J Med. 2012;79:232-245. [PMID: 22499494 DOI: 10.1002/msj.21298] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
64 McNally ME, Collins A, Wojcik SE, Liu J, Henry JC, Jiang J, Schmittgen T, Bloomston M. Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma. HPB (Oxford). 2013;15:260-264. [PMID: 23458262 DOI: 10.1111/j.1477-2574.2012.00523.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
65 Matsuo K, Rocha FG, Ito K, D’Angelica MI, Allen PJ, Fong Y, Dematteo RP, Gonen M, Endo I, Jarnagin WR. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg. 2012;215:343-355. [PMID: 22749003 DOI: 10.1016/j.jamcollsurg.2012.05.025] [Cited by in Crossref: 126] [Cited by in F6Publishing: 121] [Article Influence: 12.6] [Reference Citation Analysis]
66 Levy MJ, Heimbach JK, Gores GJ. Endoscopic ultrasound staging of cholangiocarcinoma. Curr Opin Gastroenterol. 2012;28:244-252. [PMID: 22274618 DOI: 10.1097/mog.0b013e32835005bc] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
67 Noji T, Miyamoto M, Kubota KC, Shinohara T, Ambo Y, Matsuno Y, Kashimura N, Hirano S. Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol 2012;10:106. [PMID: 22681770 DOI: 10.1186/1477-7819-10-106] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
68 Chatelain D, Farges O, Fuks D, Trouillet N, Pruvot FR, Regimbeau J. Assessment of pathology reports on hilar cholangiocarcinoma: The results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group. Journal of Hepatology 2012;56:1121-8. [DOI: 10.1016/j.jhep.2011.12.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
69 Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012; 143: 88-98. quiz e14. [PMID: 22504095 DOI: 10.1053/j.gastro.2012.04.008] [Cited by in Crossref: 311] [Cited by in F6Publishing: 320] [Article Influence: 31.1] [Reference Citation Analysis]
70 de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer. 2012;118:4737-4747. [PMID: 22415526 DOI: 10.1002/cncr.27492] [Cited by in Crossref: 119] [Cited by in F6Publishing: 124] [Article Influence: 11.9] [Reference Citation Analysis]
71 Ojima H. Clinicopathological significance of growth factors and their receptors as potential therapeutic targets for biliary tract carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2012;19:319-25. [DOI: 10.1007/s00534-011-0497-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Siddiqui AA, Mehendiratta V, Jackson W, Loren DE, Kowalski TE, Eloubeidi MA. Identification of cholangiocarcinoma by using the Spyglass Spyscope system for peroral cholangioscopy and biopsy collection. Clin Gastroenterol Hepatol. 2012;10:466-71; quiz e48. [PMID: 22178463 DOI: 10.1016/j.cgh.2011.12.021] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
73 Cannon RM, Brock G, Buell JF. Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford). 2012;14:142-149. [PMID: 22221577 DOI: 10.1111/j.1477-2574.2011.00419.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
74 Morofuji N, Ojima H, Onaya H, Okusaka T, Shimada K, Sakamoto Y, Esaki M, Nara S, Kosuge T, Asahina D. Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma. J Proteomics. 2012;75:1577-1589. [PMID: 22155129 DOI: 10.1016/j.jprot.2011.11.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
75 Saxena A, Chua TC, Chu FC, Morris DL. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg. 2011;202:310-320. [PMID: 21871986 DOI: 10.1016/j.amjsurg.2010.08.041] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
76 Ruys AT, Kate FJ, Busch OR, Engelbrecht MR, Gouma DJ, van Gulik TM. Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter? HPB (Oxford). 2011;13:881-886. [PMID: 22081924 DOI: 10.1111/j.1477-2574.2011.00389.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
77 de Jong MC, Hong SM, Augustine MM, Goggins MG, Wolfgang CL, Hirose K, Schulick RD, Choti MA, Anders RA, Pawlik TM. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Arch Surg. 2011;146:697-703. [PMID: 21690446 DOI: 10.1001/archsurg.2011.122] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
78 Schiffman SC, Reuter NP, McMasters KM, Scoggins CR, Martin RC. Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol. 2012;105:91-96. [PMID: 21815152 DOI: 10.1002/jso.22054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
79 Hemming AW, Mekeel K, Khanna A, Baquerizo A, Kim RD. Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg 2011;212:604-13; discussion 613-6. [PMID: 21463797 DOI: 10.1016/j.jamcollsurg.2010.12.028] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
80 Zografos GN, Farfaras A, Zagouri F, Chrysikos D, Karaliotas K. Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreat Dis Int 2011;10:10-20. [PMID: 21269929 DOI: 10.1016/s1499-3872(11)60001-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
81 Li H, Qin Y, Cui Y, Chen H, Hao X, Li Q. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg. 2011;28:226-231. [PMID: 21540611 DOI: 10.1159/000327361] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
82 Heimbach JK, Sanchez W, Rosen CB, Gores GJ. Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford). 2011;13:356-360. [PMID: 21492336 DOI: 10.1111/j.1477-2574.2011.00298.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 173] [Article Influence: 12.7] [Reference Citation Analysis]
83 Ruys AT, Bennink RJ, van Westreenen HL, Engelbrecht MR, Busch OR, Gouma DJ, van Gulik TM. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma. HPB (Oxford. ). 2011;13:256-262. [PMID: 21418131 DOI: 10.1111/j.1477-2574.2010.00280.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
84 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2(2): 94-107 [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
85 Ramacciato G, Nigri G, Bellagamba R, Petrucciani N, Ravaioli M, Cescon M, Del Gaudio M, Ercolani G, Di Benedetto F, Cautero N, Quintini C, Cucchetti A, Lauro A, Miller C, Pinna AD. Univariate and Multivariate Analysis of Prognostic Factors in the Surgical Treatment of Hilar Cholangiocarcinoma. The American Surgeon 2010;76:1260-8. [DOI: 10.1177/000313481007601129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
86 Shimada K, Nara S, Esaki M, Sakamoto Y, Kosuge T, Hiraoka N. Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum. Br J Surg. 2011;98:117-123. [PMID: 21136566 DOI: 10.1002/bjs.7262] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
87 Matull WR, Dhar DK, Ayaru L, Sandanayake NS, Chapman MH, Dias A, Bridgewater J, Webster GJ, Bong JJ, Davidson BR, Pereira SP. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int 2011;31:99-107. [PMID: 20846273 DOI: 10.1111/j.1478-3231.2010.02345.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
88 Kim JE, Lee JM, Kim SH, Baek JH, Moon SK, Yu IS, Lee JY, Han JK, Choi BI. Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology. 2010;257:364-372. [PMID: 20829532 DOI: 10.1148/radiol.10092105] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
89 Yasuda Y, Larsen PN, Ishibashi T, Yamashita K, Toei H. Resection of hilar cholangiocarcinoma with left hepatectomy after pre-operative embolization of the proper hepatic artery. HPB (Oxford) 2010;12:147-52. [PMID: 20495660 DOI: 10.1111/j.1477-2574.2009.00152.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
90 Alvaro D, Cannizzaro R, Labianca R, Valvo F, Farinati F, Italian Society of Gastroenterology (SIGE), Italian Association of Hospital Gastroenterology (AIGO), Italian Association of Medical Oncology (AIOM), Italian Association of Oncological Radiotherapy (AIRO). Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Dig Liver Dis. 2010;42:831-838. [PMID: 20702152 DOI: 10.1016/j.dld.2010.06.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
91 Liu F, Li Y, Wei Y, Li B. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? Dig Dis Sci. 2011;56:663-672. [PMID: 20635143 DOI: 10.1007/s10620-010-1338-7] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
92 Parikh AA, Abdalla EK, Vauthey JN. Operative considerations in resection of hilar cholangiocarcinoma. HPB (Oxford). 2005;7:254-258. [PMID: 18333202 DOI: 10.1080/13651820500373093] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
93 Ryoo I, Lee JM, Chung YE, Park HS, Kim SH, Han JK, Choi BI. Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer. Invest Radiol. 2010;45:217-224. [PMID: 20195160 DOI: 10.1097/rli.0b013e3181d2eeb1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
94 Kennedy TJ, Yopp A, Qin Y, Zhao B, Guo P, Liu F, Schwartz LH, Allen P, D’Angelica M, Fong Y. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford). 2009;11:445-451. [PMID: 19768150 DOI: 10.1111/j.1477-2574.2009.00090.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 8.1] [Reference Citation Analysis]
95 Konishi M, Iwasaki M, Ochiai A, Hasebe T, Ojima H, Yanagisawa A. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. British Journal of Surgery 2010;97:1363-8. [DOI: 10.1002/bjs.7122] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
96 Malago M, Frilling A, Li J, Lang H, Broelsch CE. Cholangiocellular carcinoma--the role of caudate lobe resection and mesohepatectomy. HPB (Oxford). 2008;10:179-182. [PMID: 18773050 DOI: 10.1080/13651820801992500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
97 Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10:190-5. [PMID: 18773053 DOI: 10.1080/13651820801992575] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
98 Capussotti L, Vigano L, Ferrero A, Muratore A. Local surgical resection of hilar cholangiocarcinoma: is there still a place? HPB (Oxford). 2008;10:174-178. [PMID: 18773049 DOI: 10.1080/13651820801992534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
99 Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int. 2010;23:692-697. [PMID: 20497401 DOI: 10.1111/j.1432-2277.2010.01108.x] [Cited by in Crossref: 162] [Cited by in F6Publishing: 184] [Article Influence: 13.5] [Reference Citation Analysis]
100 Bridgewater J, Imber C. New advances in the management of biliary tract cancer. HPB (Oxford) 2007;9:104-11. [PMID: 18333124 DOI: 10.1080/13651820701216216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
101 Witzigmann H, Lang H, Lauer H. Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford). 2008;10:154-160. [PMID: 18773044 DOI: 10.1080/13651820801992567] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
102 Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford). 2008;10:130-133. [PMID: 18773090 DOI: 10.1080/13651820801992666] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 6.3] [Reference Citation Analysis]
103 Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc. 2009;41:4023-4035. [PMID: 20005336 DOI: 10.1016/j.transproceed.2009.11.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
104 Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Surg Clin North Am. 2010;90:251-263. [PMID: 20362785 DOI: 10.1016/j.suc.2010.01.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
105 Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Capelli P, Pedica F, Nicoli P, Conci S, Iacono C. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol 2010;101:111-5. [PMID: 19953578 DOI: 10.1002/jso.21452] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
106 Ercolani G, Zanello M, Grazi GL, Cescon M, Ravaioli M, Del Gaudio M, Vetrone G, Cucchetti A, Brandi G, Ramacciato G, Pinna AD. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Sci. 2010;17:329-337. [PMID: 20464563 DOI: 10.1007/s00534-009-0249-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
107 Bork U, Koch M, Büchler MW, Weitz J. [Surgery of hepatobiliary tumors]. Chirurg 2010;81:111-16. [PMID: 20076936 DOI: 10.1007/s00104-009-1812-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Robles R, Parrilla P, Ramírez P, Sánchez-Bueno F, Marín C, Pastor P, Pons JA, Acosta F, Pérez-Flores D, De La Peña Morales J. [Liver transplantation increases R0 resection and survival of patients with a non-disseminated unresectable Klatskin tumour]. Cir Esp 2010;87:82-8. [PMID: 20074713 DOI: 10.1016/j.ciresp.2009.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
109 Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg. 2010;97:56-64. [PMID: 19937985 DOI: 10.1002/bjs.6788] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 5.2] [Reference Citation Analysis]
110 Ojima H, Yoshikawa D, Ino Y, Shimizu H, Miyamoto M, Kokubu A, Hiraoka N, Morofuji N, Kondo T, Onaya H. Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment. Cancer Sci. 2010;101:882-888. [PMID: 20088962 DOI: 10.1111/j.1349-7006.2009.01462.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
111 Unno M, Katayose Y, Rikiyama T, Yoshida H, Yamamoto K, Morikawa T, Hayashi H, Motoi F, Egawa S. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:463-469. [PMID: 19941010 DOI: 10.1007/s00534-009-0206-3] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
112 Sakamoto Y, Shimada K, Nara S, Esaki M, Ojima H, Sano T, Yamamoto J, Kosuge T. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg. 2010;14:335-343. [PMID: 19902311 DOI: 10.1007/s11605-009-1072-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
113 Figueras J, Codina-barreras A, López-ben S, Soriano J, Pardina B, Falgueras L, Castro E, Torres-bahi S, Ortiz R, Diaz E, Maroto A, Canals E. Las hepatectomías mayores en pacientes con colangiocarcinoma e ictericia son seguras. Cirugía Española 2009;86:296-302. [DOI: 10.1016/j.ciresp.2009.05.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
114 Chen XP, Lau WY, Huang ZY, Zhang ZW, Chen YF, Zhang WG, Qiu FZ. Extent of liver resection for hilar cholangiocarcinoma. Br J Surg. 2009;96:1167-1175. [PMID: 19705374 DOI: 10.1002/bjs.6618] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
115 Rocha FG, Matsuo K, Blumgart LH, Jarnagin WR. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreat Sci 2010;17:490-6. [PMID: 19806295 DOI: 10.1007/s00534-009-0205-4] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
116 Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Gamblin TC. Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol 2009;16:3308-15. [PMID: 19774418 DOI: 10.1245/s10434-009-0701-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
117 Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15(34): 4240-4262 [PMID: 19750567 DOI: 10.3748/wjg.15.4240] [Cited by in CrossRef: 181] [Cited by in F6Publishing: 165] [Article Influence: 13.9] [Reference Citation Analysis]
118 Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210-218. [PMID: 19638920 DOI: 10.1097/sla.0b013e3181afe0ab] [Cited by in Crossref: 153] [Cited by in F6Publishing: 139] [Article Influence: 11.8] [Reference Citation Analysis]
119 Heimbach J. Hilar Cholangiocarcinoma and Liver Transplantation. Transplantation 2009;88:299-300. [DOI: 10.1097/tp.0b013e3181adca5a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
120 Schwartz JJ, Hutson WR, Gayowski TJ, Sorensen JB. Liver Transplantation for Cholangiocarcinoma. Transplantation 2009;88:295-8. [DOI: 10.1097/tp.0b013e3181adc9e5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
121 Figueras J, Codina-Barreras A, López-Ben S, Soriano J, Pardina B, Falgueras L, Castro E, Torres-Bahi S, Ortiz R, Diaz E. [Major hepatectomies are safe in patients with cholangiocarcinoma and jaundice]. Cir Esp. 2009;86:296-302. [PMID: 19646686 DOI: 10.1016/s2173-5077(09)70100-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
122 Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, Del Gaudio M, Pinna AD. Trends in Perioperative Outcome After Hepatic Resection: Analysis of 1500 Consecutive Unselected Cases Over 20 Years. Annals of Surgery 2009;249:995-1002. [DOI: 10.1097/sla.0b013e3181a63c74] [Cited by in Crossref: 155] [Cited by in F6Publishing: 160] [Article Influence: 11.9] [Reference Citation Analysis]
123 Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, Nakashima A, Sueda T. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg. 2009;13:1470-1479. [PMID: 19421824 DOI: 10.1007/s11605-009-0900-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 5.5] [Reference Citation Analysis]
124 Seyama Y, Kokudo N, Makuuchi M. Radical Resection of Biliary Tract Cancers and the Role of Extended Lymphadenectomy. Surgical Oncology Clinics of North America 2009;18:339-59. [DOI: 10.1016/j.soc.2008.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
125 Akoad M, Jenkins R. Proximal biliary malignancy. Surg Clin North Am. 2008;88:1409-1428, x-xi. [PMID: 18992602 DOI: 10.1016/j.suc.2008.07.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
126 Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T, Ojima H. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery. 2009;145:411-416. [PMID: 19303990 DOI: 10.1016/j.surg.2008.11.010] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 6.5] [Reference Citation Analysis]
127 Konishi M, Ochiai A, Ojima H, Hasebe T, Mano M, Ohta T, Ito I, Sasaki K, Yasukawa S, Shimada K, Iwasaki M, Yanagisawa A. A new histological classification for intra-operative histological examination of the ductal resection margin in cholangiocarcinoma. Cancer Science 2009;100:255-60. [DOI: 10.1111/j.1349-7006.2008.01043.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
128 Sakata J, Shirai Y, Tsuchiya Y, Wakai T, Nomura T, Hatakeyama K. Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbecks Arch Surg. 2009;394:1065-1072. [PMID: 19169703 DOI: 10.1007/s00423-009-0464-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
129 Machimoto T, Doi R, Ogawa K, Masui T, Seo S, Uemoto S. Abdominal wall recurrence of Hilar bile duct cancer 12 years after a curative resection: report of a case. Surg Today 2009;39:72-6. [PMID: 19132474 DOI: 10.1007/s00595-008-3791-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
130 Ojima H, Kanai Y, Iwasaki M, Hiraoka N, Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Sakamoto M, Hirohashi S. Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 2009;100:62-70. [PMID: 19038006 DOI: 10.1111/j.1349-7006.2008.01009.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
131 Ustundag Y, Bayraktar Y. Cholangiocarcinoma: A compact review of the literature. World J Gastroenterol 2008; 14(42): 6458-6466 [PMID: 19030196 DOI: 10.3748/wjg.14.6458] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
132 Li J, Kuehl H, Grabellus F, Müller SP, Radunz S, Antoch G, Nadalin S, Broelsch CE, Gerken G, Paul A, Kaiser GM. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol 2008;98:438-43. [DOI: 10.1002/jso.21136] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
133 Aljiffry M, Abdulelah A, Walsh M, Peltekian K, Alwayn I, Molinari M. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg. 2009;208:134-147. [PMID: 19228515 DOI: 10.1016/j.jamcollsurg.2008.09.007] [Cited by in Crossref: 148] [Cited by in F6Publishing: 143] [Article Influence: 10.6] [Reference Citation Analysis]
134 van der Gaag NA, Kloek JJ, de Castro SM, Busch OR, van Gulik TM, Gouma DJ. Preoperative biliary drainage in patients with obstructive jaundice: history and current status. J Gastrointest Surg. 2009;13:814-820. [PMID: 18726134 DOI: 10.1007/s11605-008-0618-4] [Cited by in Crossref: 107] [Cited by in F6Publishing: 111] [Article Influence: 7.6] [Reference Citation Analysis]
135 Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248:273-279. [PMID: 18650638 DOI: 10.1097/sla.0b013e31817f2bfd] [Cited by in Crossref: 120] [Cited by in F6Publishing: 116] [Article Influence: 8.6] [Reference Citation Analysis]
136 Regimbeau J, Fuks D, Chatelain D, Riboulot M, Delcenserie R, Yzet T. Prise en charge chirurgicale du cholangiocarcinome hilaire résécable. Gastroentérologie Clinique et Biologique 2008;32:620-31. [DOI: 10.1016/j.gcb.2008.04.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
137 Tajiri T, Yoshida H, Mamada Y, Taniai N, Yokomuro S, Mizuguchi Y. Diagnosis and initial management of cholangiocarcinoma with obstructive jaundice. World J Gastroenterol 2008; 14(19): 3000-3005 [PMID: 18494050 DOI: 10.3748/wjg.14.3000] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
138 Aydin U, Yedibela S, Yazici P, Aydinli B, Zeytunlu M, Kilic M, Coker A. A new technique of biliary reconstruction after "high hilar resection" of hilar cholangiocarcinoma with tumor extension to secondary and tertiary biliary radicals. Ann Surg Oncol. 2008;15:1871-1879. [PMID: 18454297 DOI: 10.1245/s10434-008-9926-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
139 Heimbach JK. Successful liver transplantation for hilar cholangiocarcinoma: . Current Opinion in Gastroenterology 2008;24:384-8. [DOI: 10.1097/mog.0b013e3282f706ce] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
140 Paik KY, Choi DW, Chung JC, Kang KT, Kim SB. Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1268-1274. [PMID: 18330655 DOI: 10.1007/s11605-008-0503-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
141 Jonas S, Benckert C, Thelen A, Lopez-hänninen E, Rösch T, Neuhaus P. Radical surgery for hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2008;34:263-71. [DOI: 10.1016/j.ejso.2007.09.024] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
142 Witzigmann H, Wiedmann M, Wittekind C, Mössner J, Hauss J. Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int 2008;105:156-61. [PMID: 19633782 DOI: 10.3238/arztebl.2008.0156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
143 Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F; Japanese Association of Biliary Surgery; Japanese Society of Hepato-Biliary-Pancreatic Surgery; Japan Society of Clinical Oncology. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008;15:41-54. [PMID: 18274843 DOI: 10.1007/s00534-007-1279-5] [Cited by in Crossref: 137] [Cited by in F6Publishing: 134] [Article Influence: 9.8] [Reference Citation Analysis]
144 Hernandez J, Cowgill SM, Al-saadi S, Villadolid D, Ross S, Kraemer E, Shapiro M, Mullinax J, Cooper J, Goldin S, Zervos E, Rosemurgy A. An Aggressive Approach to Extrahepatic Cholangiocarcinomas Is Warranted: Margin Status Does Not Impact Survival after Resection. Ann Surg Oncol 2008;15:807-14. [DOI: 10.1245/s10434-007-9756-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
145 Endo I, Shimada H, Sugita M, Fujii Y, Morioka D, Takeda K, Sugae S, Tanaka K, Togo S, Bourquain H. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery. 2007;142:666-675. [PMID: 17981186 DOI: 10.1016/j.surg.2007.05.018] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 5.4] [Reference Citation Analysis]
146 Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Tsuchiya K, Kondo K. Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1033-1040. [PMID: 18085342 DOI: 10.1007/s11605-007-0453-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
147 Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol 2008;15:590-9. [PMID: 18057991 DOI: 10.1245/s10434-007-9687-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
148 Chen RF, Li ZH, Zhou JJ, Wang J, Chen JS, Lin Q, Tang QB, Peng NF, Jiang ZP, Zhou QB. Preoperative evaluation with T-staging system for hilar cholangiocarcinoma. World J Gastroenterol 2007; 13(43): 5754-5759 [PMID: 17963304 DOI: 10.3748/wjg.v13.i43.5754] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
149 Lang H, Kaiser GM, Zöpf T, Sotiropoulos GC, Frilling A, Malagó M, Broelsch CE. [Surgical therapy of hilar cholangiocarcinoma]. Chirurg 2006;77:325-34. [PMID: 16568258 DOI: 10.1007/s00104-006-1177-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
150 Muscari F. Prise en charge du cholangiocarcinome hilaire. Journal de Chirurgie 2007;144:385-92. [DOI: 10.1016/s0021-7697(07)73992-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
151 Sano T, Shimada K, Sakamoto Y, Esaki M, Kosuge T. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J Hepatobiliary Pancreat Surg. 2007;14:455-462. [PMID: 17909713 DOI: 10.1007/s00534-006-1194-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
152 Cleary SP, Dawson LA, Knox JJ, Gallinger S. Cancer of the gallbladder and extrahepatic bile ducts. Curr Probl Surg. 2007;44:396-482. [PMID: 17693325 DOI: 10.1067/j.cpsurg.2007.04.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
153 Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg. 2007;31:1256-1263. [PMID: 17453285 DOI: 10.1007/s00268-007-9001-y] [Cited by in Crossref: 129] [Cited by in F6Publishing: 130] [Article Influence: 8.6] [Reference Citation Analysis]
154 Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg. 2007;11:1488-1496; discussion 1496-1497. [PMID: 17805937 DOI: 10.1007/s11605-007-0282-0] [Cited by in Crossref: 148] [Cited by in F6Publishing: 210] [Article Influence: 9.9] [Reference Citation Analysis]
155 Cormier JN, Vauthey JN. Biliary tract cancer. Curr Opin Gastroenterol. 2000;16:437-443. [PMID: 17031117 DOI: 10.1097/00001574-200009000-00009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
156 DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755-762. [PMID: 17457168 DOI: 10.1097/01.sla.0000251366.62632] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755-762. [PMID: 17457168 DOI: 10.1097/01.sla.0000251366.62632.d3] [Cited by in Crossref: 777] [Cited by in F6Publishing: 765] [Article Influence: 51.8] [Reference Citation Analysis]
158 Ishihara S, Miyakawa S, Takada T, Takasaki K, Nimura Y, Tanaka M, Miyazaki M, Nagakawa T, Kayahara M, Horiguchi A. Status of surgical treatment of biliary tract cancer. Dig Surg. 2007;24:131-136. [PMID: 17446708 DOI: 10.1159/000101901] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
159 Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13(10): 1505-1515 [PMID: 17461441 DOI: 10.3748/wjg.v13.i10.1505] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 77] [Article Influence: 5.9] [Reference Citation Analysis]
160 Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Pedersen R, Kremers W, Nyberg SL, Ishitani MB, Rosen CB. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation. 2006;82:1703-1707. [PMID: 17198263 DOI: 10.1097/01.tp.0000253551.43583.d1] [Cited by in Crossref: 150] [Cited by in F6Publishing: 128] [Article Influence: 10.0] [Reference Citation Analysis]
161 Cha JM, Kim MH, Lee SK, Seo DW, Lee SS, Lee JH, Lee SG, Jang SJ. Clinicopathological review of 61 patients with early bile duct cancer. Clin Oncol (R Coll Radiol). 2006;18:669-677. [PMID: 17100152 DOI: 10.1016/j.clon.2006.07.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
162 Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg. 2006;93:1488-1494. [PMID: 17048280 DOI: 10.1002/bjs.5482] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
163 Nagorney DM, Kendrick ML. Hepatic resection in the treatment of hilar cholangiocarcinoma. Adv Surg. 2006;40:159-171. [PMID: 17163100 DOI: 10.1016/j.yasu.2006.05.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
164 Baton O, Azoulay D, Adam DV, Castaing D. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg. 2007;204:250-260. [PMID: 17254929 DOI: 10.1016/j.jamcollsurg.2006.10.028] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
165 Pavey DA, Gress FG. The role of EUS-guided FNA for the evaluation of biliary strictures. Gastrointest Endosc. 2006;64:334-337. [PMID: 16923478 DOI: 10.1016/j.gie.2006.03.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
166 IJitsma AJ, Appeltans BM, de Jong KP, Porte RJ, Peeters PM, Slooff MJ. Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases. J Gastrointest Surg. 2004;8:686-694. [PMID: 15358329 DOI: 10.1016/j.gassur.2004.04.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
167 Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M, Ben-Josef E. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2006;66:772-779. [PMID: 17011452 DOI: 10.1016/j.ijrobp.2006.05.061] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 5.3] [Reference Citation Analysis]
168 Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006;244:240-247. [PMID: 16858186 DOI: 10.1097/01.sla.0000217605.66519.38] [Cited by in Crossref: 164] [Cited by in F6Publishing: 165] [Article Influence: 10.3] [Reference Citation Analysis]
169 Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244:230-239. [PMID: 16858185 DOI: 10.1097/01.sla.0000217639.10331.47] [Cited by in Crossref: 201] [Cited by in F6Publishing: 174] [Article Influence: 12.6] [Reference Citation Analysis]
170 Hemming AW, Kim RD, Mekeel KL, Fujita S, Reed AI, Foley DP, Howard RJ. Portal Vein Resection for Hilar Cholangiocarcinoma. The American Surgeon 2006;72:599-605. [DOI: 10.1177/000313480607200706] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
171 Dinant S, Gerhards MF, Rauws EAJ, Busch ORC, Gouma DJ, van Gulik TM. Improved Outcome of Resection of Hilar Cholangiocarcinoma (Klatskin Tumor). Ann Surg Oncol 2006;13:872-80. [DOI: 10.1245/aso.2006.05.053] [Cited by in Crossref: 139] [Cited by in F6Publishing: 133] [Article Influence: 8.7] [Reference Citation Analysis]
172 Otto G. Diagnostic and surgical approaches in hilar cholangiocarcinoma. Int J Colorectal Dis 2007;22:101-8. [PMID: 16575606 DOI: 10.1007/s00384-005-0070-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
173 Ramacciato G, Corigliano N, Mercantini P, Di Benedetto F, Masetti M, Ercolani G, Lauro A, De Ruvo N, Pinna AD. [Prognostic factors after surgical resection for hilar cholangiocarcinoma]. Ann Chir 2006;131:379-85. [PMID: 16806037 DOI: 10.1016/j.anchir.2006.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
174 Lai EC, Lau WY. Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg. 2005;75:981-985. [PMID: 16336393 DOI: 10.1111/j.1445-2197.2005.03595.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
175 Sakamoto Y, Sano T, Shimada K, Kosuge T, Kimata Y, Sakuraba M, Yamamoto J, Ojima H. Clinical significance of reconstruction of the right hepatic artery for biliary malignancy. Langenbecks Arch Surg. 2006;391:203-208. [PMID: 16525853 DOI: 10.1007/s00423-006-0026-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
176 Shimada K, Sano T, Sakamoto Y, Kosuge T. A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer. 2005;104:1939-1947. [PMID: 16177997 DOI: 10.1002/cncr.21461] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 3.9] [Reference Citation Analysis]
177 Zervos EE, Osborne D, Goldin SB, Villadolid DV, Thometz DP, Durkin A, Carey LC, Rosemurgy AS. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg. 2005;190:810-815. [PMID: 16226963 DOI: 10.1016/j.amjsurg.2005.07.025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
178 Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, Gores GJ, Nagorney DM. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451-8; discussion 458-61. [PMID: 16135931 DOI: 10.1097/01.sla.0000179678.13285.fa] [Cited by in Crossref: 142] [Cited by in F6Publishing: 233] [Article Influence: 8.4] [Reference Citation Analysis]
179 Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Gastrointest Endosc Clin N Am. 2005;15:497-511, viii-viix. [PMID: 15990054 DOI: 10.1016/j.giec.2005.03.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
180 Yamada T, Arai T, Nagino M, Oda K, Shoda J, Suzuki H, Sugiyama Y, Nimura Y. Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer. Langenbecks Arch Surg 2005;390:421-9. [PMID: 15965653 DOI: 10.1007/s00423-005-0564-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
181 Esaki M, Shimada K, Sano T, Sakamoto Y, Kosuge T, Ojima H. Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparison between macroscopic and microscopic tumor thrombus. J Surg Oncol 2005;90:226-32. [PMID: 15906365 DOI: 10.1002/jso.20260] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
182 Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693-699; discussion 699-702. [PMID: 15849505 DOI: 10.1097/01.sla.0000160701.38945.82] [Cited by in Crossref: 245] [Cited by in F6Publishing: 223] [Article Influence: 14.4] [Reference Citation Analysis]
183 Shimada K, Sano T, Sakamoto Y, Kosuge T. Safety and Effectiveness of Left Hepatic Trisegmentectomy for Hilar Cholangiocarcinoma. World J Surg 2005;29:723-7. [DOI: 10.1007/s00268-005-7704-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
184 Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J, Yamasaki S, Takayama T, Makuuchi M. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery. 2005;137:396-402. [PMID: 15800484 DOI: 10.1016/j.surg.2004.10.008] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 6.2] [Reference Citation Analysis]
185 Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005;103:1210-1216. [PMID: 15685618 DOI: 10.1002/cncr.20906] [Cited by in Crossref: 166] [Cited by in F6Publishing: 154] [Article Influence: 9.8] [Reference Citation Analysis]
186 Clayton RA, Clarke DL, Currie EJ, Madhavan KK, Parks RW, Garden OJ. Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy. Surgeon. 2003;1:32-38. [PMID: 15568422 DOI: 10.1016/s1479-666x(03)80006-9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
187 Kraus T, Klenke F, Schemmer P, Büchler M. Chirurgische Strategie beim Karzinom der Gallenblase und der extrahepatischen Gallenwege. Visc Med 2004;20:272-8. [DOI: 10.1159/000083012] [Reference Citation Analysis]
188 Strey C, Golling M, Schwarz W, Bechstein W. Chirurgische Therapie des Cholangiokarzinoms. Visc Med 2004;20:279-85. [DOI: 10.1159/000083017] [Reference Citation Analysis]
189 Zervos EE, Pearson H, Durkin AJ, Thometz D, Rosemurgy P, Kelley S, Rosemurgy AS. In-continuity hepatic resection for advanced hilar cholangiocarcinoma. Am J Surg. 2004;188:584-588. [PMID: 15546575 DOI: 10.1016/j.amjsurg.2004.07.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
190 Ueda J, Chijiiwa K, Nakano K. Cyclin expression in the atrophying and proliferating lobes of the liver after portal vein branch ligation and hepatectomy in rats. J Surg Res 2004;120:89-96. [PMID: 15172194 DOI: 10.1016/j.jss.2003.11.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
191 Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, Katoh H. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95-101. [PMID: 15213624 DOI: 10.1097/01.sla.0000129491.43855.6b] [Cited by in Crossref: 219] [Cited by in F6Publishing: 200] [Article Influence: 12.2] [Reference Citation Analysis]
192 Bold RJ, Goodnight JE. Hilar cholangiocarcinoma: surgical and endoscopic approaches. Surg Clin North Am. 2004;84:525-542. [PMID: 15062660 DOI: 10.1016/s0039-6109(03)00232-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
193 Terashi T, Aishima S, Taguchi K, Asayama Y, Sugimachi K, Matsuura S, Shimada M, Maehara S, Maehara Y, Tsuneyoshi M. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma. Liver Int. 2004;24:38-45. [PMID: 15101999 DOI: 10.1111/j.1478-3231.2004.00886.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
194 Otto G, Thies J, Hoppe-Lotichius M, Bittinger F, Pitton MB, Hadian A. [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver]. Chirurg 2004;75:59-65. [PMID: 14740129 DOI: 10.1007/s00104-003-0747-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
195 Eloubeidi MA, Chen VK, Jhala NC, Eltoum IE, Jhala D, Chhieng DC, Syed SA, Vickers SM, Mel Wilcox C. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clinical Gastroenterology and Hepatology 2004;2:209-13. [DOI: 10.1016/s1542-3565(04)00005-9] [Cited by in Crossref: 222] [Cited by in F6Publishing: 169] [Article Influence: 12.3] [Reference Citation Analysis]
196 Robles R, Figueras J, Turrión VS, Margarit C, Moya A, Varo E, Calleja J, Valdivieso A, Valdecasas JC, López P, Gómez M, de Vicente E, Loinaz C, Santoyo J, Fleitas M, Bernardos A, Lladó L, Ramírez P, Bueno FS, Jaurrieta E, Parrilla P. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004;239:265-71. [PMID: 14745336 DOI: 10.1097/01.sla.0000108702.45715.81] [Cited by in Crossref: 194] [Cited by in F6Publishing: 184] [Article Influence: 10.8] [Reference Citation Analysis]
197 Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, Thonke F, Bobrowski C, Topalidis T, Soehendra N. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol. 2004;99:45-51. [PMID: 14687140 DOI: 10.1046/j.1572-0241.2003.04006.x] [Cited by in Crossref: 176] [Cited by in F6Publishing: 197] [Article Influence: 9.8] [Reference Citation Analysis]
198 Annovazzi A, Peeters M, Maenhout A, Signore A, Dierckx R, Van De Wiele C. 18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract. Gastroenterology 2003;125:1235-45. [PMID: 14517805 DOI: 10.1016/s0016-5085(03)01208-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
199 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 10.1097/00000658-200307000-00010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
200 Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92. [PMID: 12832969 DOI: 10.1097/01.sla.0000074984.83031.02] [Cited by in Crossref: 143] [Cited by in F6Publishing: 200] [Article Influence: 7.5] [Reference Citation Analysis]
201 Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92. [PMID: 12832969 DOI: 10.1097/00000658-200307000-00011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
202 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 10.1097/01.sla.0000074960.55004.72.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
203 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 10.1097/01.sla.0000074960.55004.72] [Cited by in Crossref: 164] [Cited by in F6Publishing: 222] [Article Influence: 8.6] [Reference Citation Analysis]
204 Shimada H, Endo I, Sugita M, Masunari H, Fujii Y, Tanaka K, Misuta K, Sekido H, Togo S. Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder. World J Surg. 2003;27:1137-1142. [PMID: 12925900 DOI: 10.1007/s00268-003-6801-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
205 Neuhaus P, Jonas S, Settmacher U, Thelen A, Benckert C, Lopez-Hänninen E, Hintze RE. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg. 2003;388:194-200. [PMID: 12819970 DOI: 10.1007/s00423-003-0383-5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 107] [Article Influence: 6.2] [Reference Citation Analysis]
206 Corvera CU, Weber SM, Jarnagin WR. Role of laparoscopy in the evaluation of biliary tract cancer. Surg Oncol Clin N Am 2002;11:877-91. [PMID: 12607577 DOI: 10.1016/s1055-3207(02)00033-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
207 Hassoun Z, Gores GJ, Rosen CB. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surg Oncol Clin N Am. 2002;11:909-921. [PMID: 12607579 DOI: 10.1016/s1055-3207(02)00036-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
208 Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg. 2003;237:201-207. [PMID: 12560778 DOI: 10.1097/01.sla.0000048446.18118.fc] [Cited by in Crossref: 22] [Cited by in F6Publishing: 33] [Article Influence: 1.2] [Reference Citation Analysis]
209 Shimada H, Endo I, Sugita M, Masunari H, Fujii Y, Tanaka K, Sekido H, Togo S. Is parenchyma-preserving hepatectomy a noble option in the surgical treatment for high-risk patients with hilar bile duct cancer? Langenbecks Arch Surg 2003;388:33-41. [DOI: 10.1007/s00423-003-0358-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
210 Chui A, Rao A, Wong J, Mann D, Leung K, Lau W. Ex situ ex vivo liver resection, partial liver autotransplantation for advanced hilar cholangiocarcinoma: a case report. Transplantation Proceedings 2003;35:402-3. [DOI: 10.1016/s0041-1345(02)03774-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
211 Ebata T, Watanabe H, Ajioka Y, Oda K, Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg. 2002;89:1260-1267. [PMID: 12296893 DOI: 10.1046/j.1365-2168.2002.02211.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 4.7] [Reference Citation Analysis]
212 Sarmiento JM, Nagorney DM. Hepatic resection in the treatment of perihilar cholangiocarcinoma. Surgical Oncology Clinics of North America 2002;11:893-908. [DOI: 10.1016/s1055-3207(02)00034-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
213 Bouma BE, Tearney G. Clinical Imaging with Optical Coherence Tomography. Academic Radiology 2002;9:942-53. [DOI: 10.1016/s1076-6332(03)80465-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
214 Ueda J, Chijiiwa K, Nakano K, Zhao G, Tanaka M. Lack of intestinal bile results in delayed liver regeneration of normal rat liver after hepatectomy accompanied by impaired cyclin E-associated kinase activity. Surgery. 2002;131:564-573. [PMID: 12019411 DOI: 10.1067/msy.2002.123008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
215 Weber SM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg. 2002;235:392-399. [PMID: 11882761 DOI: 10.1097/00000658-200203000-00011] [Cited by in Crossref: 191] [Cited by in F6Publishing: 136] [Article Influence: 9.6] [Reference Citation Analysis]
216 Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Schäfer H, Buchert R, Rogiers X, Clausen M. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001;22:1277-85. [PMID: 11711897 DOI: 10.1097/00006231-200112000-00002] [Cited by in Crossref: 112] [Cited by in F6Publishing: 92] [Article Influence: 5.6] [Reference Citation Analysis]
217 Poneros JM, Tearney GJ, Shiskov M, Kelsey PB, Lauwers GY, Nishioka NS, Bouma BE. Optical coherence tomography of the biliary tree during ERCP. Gastrointest Endosc 2002;55:84-8. [PMID: 11756925 DOI: 10.1067/mge.2002.120098] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 3.5] [Reference Citation Analysis]
218 Sugimachi K, Aishima S, Taguchi K, Tanaka S, Shimada M, Kajiyama K, Sugimachi K, Tsuneyoshi M. The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma. J Hepatol. 2001;35:74-79. [PMID: 11495045 DOI: 10.1016/S0168-8278(01)00079-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
219 Johnson SR, Kelly BS, Pennington LJ, Hanto DW. A single center experience with extrahepatic cholangiocarcinomas. Surgery 2001;130:584-90; discussion 590-2. [PMID: 11602888 DOI: 10.1067/msy.2001.117104] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
220 Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:1463-1466. [PMID: 11683741 DOI: 10.1046/j.0007-1323.2001.01879.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 124] [Article Influence: 6.0] [Reference Citation Analysis]
221 Vellar ID. Preliminary study of the anatomy of the venous drainage of the intrahepatic and extrahepatic bile ducts and its relevance to the practice of hepatobiliary surgery. ANZ J Surg. 2001;71:418-422. [PMID: 11450918 DOI: 10.1046/j.1440-1622.2001.02150.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
222 Braga HJ, Imam K, Bluemke DA. MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension. AJR Am J Roentgenol. 2001;177:111-114. [PMID: 11418408 DOI: 10.2214/ajr.177.1.1770111] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
223 Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385-392. [PMID: 11224627 DOI: 10.1097/00000658-200103000-00013] [Cited by in Crossref: 222] [Cited by in F6Publishing: 199] [Article Influence: 10.6] [Reference Citation Analysis]
224 Marianne O. Photodynamic therapy in the biliary tract. Curr Gastroenterol Rep 2001;3:154-9. [DOI: 10.1007/s11894-001-0013-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
225 Furukawa H, Iwata R, Moriyama N. Angiographic assessment of the right hepatic artery for encasement by hilar cholangiocarcinoma: Comparison between antero-posterior and right anterior oblique projections. Cardiovasc Intervent Radiol 2001;24:37-41. [DOI: 10.1007/s002700000392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
226 Fondevila C, Mans E, Fuster J, Grande L, García-valdecasas J, Ferrer J, Visa J. Tumor de Klatskin con invasión de la vena porta. Utilización de injertos vasculares criopreservados tras la resección quirúrgica radical. Cirugía Española 2001;70:200-5. [DOI: 10.1016/s0009-739x(01)71878-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
227 Fritscher-ravens A, Broering DC, Sriram PV, Topalidis T, Jaeckle S, Thonke F, Soehendra N. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: A case series. Gastrointestinal Endoscopy 2000;52:534-40. [DOI: 10.1067/mge.2000.109589] [Cited by in Crossref: 123] [Cited by in F6Publishing: 147] [Article Influence: 5.6] [Reference Citation Analysis]